These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15202090)

  • 21. The serum nitric oxide levels in patients with Duchenne muscular dystrophy.
    Gücüyener K; Ergenekon E; Erbas D; Pinarli G; Serdaroğlu A
    Brain Dev; 2000 May; 22(3):181-3. PubMed ID: 10814901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion analysis and clinical correlations in patients with Xp21 linked muscular dystrophy.
    Ulgenalp A; Giray O; Bora E; Hizli T; Kurul S; Sağin-Saylam G; Karasoy H; Uran N; Dizdarer G; Tütüncüoğlu S; Dirik E; Ozkinay F; Erçal D
    Turk J Pediatr; 2004; 46(4):333-8. PubMed ID: 15641267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
    Schwartz M; Hertz JM; Sveen ML; Vissing J
    Neurology; 2005 May; 64(9):1635-7. PubMed ID: 15883334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic strategies for Duchenne and Becker dystrophies.
    Voisin V; de la Porte S
    Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
    Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete atrioventricular block in Becker muscular dystrophy.
    Akdemir R; Ozhan H; Gunduz H; Yazici M; Erbilen E; Uyan C; Imirzalioglu N
    N Z Med J; 2004 May; 117(1194):U895. PubMed ID: 15156213
    [No Abstract]   [Full Text] [Related]  

  • 28. Immobility reduces muscle fiber necrosis in dystrophin deficient muscular dystrophy.
    Kimura S; Ikezawa M; Nomura K; Ito K; Ozasa S; Ueno H; Yoshioka K; Yano S; Yamashita T; Matuskura M; Miike T
    Brain Dev; 2006 Aug; 28(7):473-6. PubMed ID: 16516424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proximal dystrophin gene deletions and protein alterations in becker muscular dystrophy.
    Novaković I; Bojić D; Todorović S; Apostolski S; Luković L; Stefanović D; Milasin J
    Ann N Y Acad Sci; 2005 Jun; 1048():406-10. PubMed ID: 16154963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endurance training improves fitness and strength in patients with Becker muscular dystrophy.
    Sveen ML; Jeppesen TD; Hauerslev S; Køber L; Krag TO; Vissing J
    Brain; 2008 Nov; 131(Pt 11):2824-31. PubMed ID: 18776212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carrier detection and prenatal diagnosis in Duchenne/Becker muscular dystrophy.
    Panigrahi I; Mittal B
    Indian Pediatr; 2001 Jun; 38(6):631-9. PubMed ID: 11418728
    [No Abstract]   [Full Text] [Related]  

  • 32. [Limb-girdle muscular dystrophy in MRI].
    Herzog H; Schröder RJ
    Rofo; 2003 Oct; 175(10):1432-4. PubMed ID: 14556115
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early symptoms of Duchenne muscular dystrophy--description of cases of an 18-month-old and an 8-year-old patient.
    Iwańczak F; Stawarski A; Potyrała M; Siedlecka-Dawidko J; Agrawal GS
    Med Sci Monit; 2000; 6(3):592-5. PubMed ID: 11208376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.
    Mayhew JE; Florence JM; Mayhew TP; Henricson EK; Leshner RT; McCarter RJ; Escolar DM
    Muscle Nerve; 2007 Jan; 35(1):36-42. PubMed ID: 16969838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interview - muscular dystrophies - worldwide search for patients].
    Walter M
    Z Orthop Unfall; 2011 Aug; 149(4):365-7. PubMed ID: 21845546
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength.
    Skalsky AJ; Han JJ; Abresch RT; Shin CS; McDonald CM
    Muscle Nerve; 2009 May; 39(5):647-51. PubMed ID: 19347922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive and psychological profile of males with Becker muscular dystrophy.
    Young HK; Barton BA; Waisbren S; Portales Dale L; Ryan MM; Webster RI; North KN
    J Child Neurol; 2008 Feb; 23(2):155-62. PubMed ID: 18056690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calpain-dependent alpha-fodrin cleavage at the sarcolemma in muscle diseases.
    Takamure M; Murata KY; Tamada Y; Azuma M; Ueno S
    Muscle Nerve; 2005 Sep; 32(3):303-9. PubMed ID: 15948206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to american academy of pediatrics recommendations for cardiac care among female carriers of duchenne and becker muscular dystrophy.
    Bobo JK; Kenneson A; Kolor K; Brown MA
    Pediatrics; 2009 Mar; 123(3):e471-5. PubMed ID: 19254982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.